Results: 162
Plasma rico en plaquetas autólogo en la cicatrización de heridas por cirugía electiva, ¿mito o realidad? Estudio prospectivo experimental
Rev. venez. cir; 76 (1), 2023
El plasma rico en plaquetas es un producto biológico definido como parte de la fracción plasmática de sangre autóloga con concentración plaquetaria por encima de la línea de base, considerándose como tecnología terapéutica endógena con potencial para estimular y acelerar la cicatrización de lo...
Therapeutics and COVID-19: living guideline - 16 September 2022
The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform, an...
Inhibidores de las Cinasas Janus/uso terapéutico, COVID-19/tratamiento farmacológico, Antivirales/uso terapéutico, Ivermectina/uso terapéutico, Hidroxicloroquina/uso terapéutico, Plasma/inmunología, Fluvoxamina/uso terapéutico, Colchicina/uso terapéutico, Inmunización Pasiva, Receptores de Interleucina-6/uso terapéutico, Lopinavir/uso terapéutico, Corticoesteroides/uso terapéutico
Reflections on the fundamental nature of homeopathic potencies: Plasma, Langmuir Adsorption and Vitalism
Int. j. high dilution res; 21 (1), 2022
There is a pressing need to develop methods and approaches that will identify the fundamental nature of homeopathic potencies. Aims: To bring together recent basic research on potencies, especially that using solvatochromic dyes, and to supplement these results with reliable obser...
Development and implementation of a COVID-19 convalescent plasma program in a middle-income economy
Hematol., Transfus. Cell Ther. (Impr.); 44 (2), 2022
Abstract Introduction Convalescent Plasma therapy is one of the therapeutic strategies that has been used for patients with the Covid-19 disease. Implementing a program with national extension to supply hospitals with this blood component is a great challenge mainly in a middle-income economy. Objectiv...
Antibody response against SARS-CoV-2 in convalescent plasma donors: Can we predict subjects' eligibility?
Hematol., Transfus. Cell Ther. (Impr.); 44 (1), 2022
Abstract Introduction As the Coronavirus Disease 2019 (COVID-19) pandemic unfolds around the world; answers related to the antibody response against the virus are necessary to develop treatment and prophylactic strategies. We attempted to understand part of the immune response of convalescent plasma don...
Aplicação do plasma de baixa temperatura sob pressão atmosférica no controle de biofilmes cariogênicos
O objetivo geral do presente estudo foi avaliar a aplicação dos jatos de plasma de baixa temperatura sob pressão atmosférica (PBTPA) produzidos por gás de argônio e hélio como gases de trabalho, no controle de biofilmes cariogênicos. Para tanto, foram estabelecidos os parâmetros físicos dos PBT...
Blood components use at two private hospitals in Belo Horizonte, Minas Gerais between July 2017 and June 2019
Hematol., Transfus. Cell Ther. (Impr.); 43 (4), 2021
ABSTRACT Introduction: A retrospective ecological longitudinal study was carried out with data on blood components use from two private hospital units that belong to the same organization located in Belo Horizonte between July 2017 and June 2019. Objectives: To describe the monthly series of red blood ...
Challenges in the production of COVID-19 convalescent plasma-analysis of donor recruitment
Hematol., Transfus. Cell Ther. (Impr.); 43 (3), 2021
Plasma convaleciente
Convalescent plasma
Rev. méd. Urug; 37 (supl.1), 2021